Firstly let me say that I think this is great news and makes me feel comfortable moving forward.
But, it does raise some questions.
a) How much have they spent?
b) How much cash is left?
c) Is this cash + improving revenue enough to avoid raising capital.
I suspect no CR required as it probably would have been part of the purchase announcement.
Anybody concur / disagree with this thought?
Polynovo’s Novosorb is a med-tech Swiss Army Knife, page-15
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.030(1.18%) |
Mkt cap ! $1.763B | |||
| Open | High | Low | Value | Volume |
| $2.53 | $2.58 | $2.46 | $1.677M | 663.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 24520 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 20316 | 10 |
View Market Depth
| Last trade - 12.43pm 21/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |